Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder
- PMID: 27163984
- DOI: 10.1001/jama.2016.3427
Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder
Comment on
-
Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.JAMA. 2016 May 10;315(18):2009-10. doi: 10.1001/jama.2016.3611. JAMA. 2016. PMID: 27163989
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical